Eric Stice, Paul Rohde, Sonja Yokum, Cara Bohon, Heather Shaw
{"title":"Response to \"Considerations in selecting comparison conditions in psychotherapy trials: Recommendations for future research\".","authors":"Eric Stice, Paul Rohde, Sonja Yokum, Cara Bohon, Heather Shaw","doi":"10.1037/ccp0000952","DOIUrl":null,"url":null,"abstract":"<p><p>Several researchers who have evaluated <i>Interpersonal Psychotherapy</i> (IPT) wrote a commentary arguing that the group-delivered IPT treatment for eating disorders that we adapted and used in a recent trial (Stice, Rohde, et al., 2023) was less effective than the new dissonance-based eating disorder treatment (<i>Body Project Treatment</i>) because the group-delivered IPT did not contain all core elements, was not developmentally appropriate, was not tailored for people with eating disorders, and because our team lacked sufficient IPT expertise. In response, we note that the group-delivered IPT that we evaluated produced higher abstinence from binge eating and compensatory weight control behaviors (40%) than did individually delivered IPT in the only trial that also evaluated this treatment with a broad range of eating disorders (33%; Fairburn et al., 2015). The fact that the group-delivered IPT produced a higher abstinence rate than individually delivered IPT for a similar spectrum of patients appears to refute the stated concerns regarding the group-delivered version of IPT because it was not less effective than individually delivered IPT. We argue it is critical to establish that a treatment significantly outperforms alternative treatments with a distinct intervention target because only an active comparator controls for the potential confounds that can drive improvement in trials, including expectancies, demand characteristics, and nonspecific therapeutic effects. We also note that IPT for the treatment of eating disorders has not significantly outperformed three alternative treatments and that the evidence base for IPT may thus be driven by expectancies, demand characteristics, and nonspecific effects. (PsycInfo Database Record (c) 2025 APA, all rights reserved).</p>","PeriodicalId":15447,"journal":{"name":"Journal of consulting and clinical psychology","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of consulting and clinical psychology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1037/ccp0000952","RegionNum":1,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Several researchers who have evaluated Interpersonal Psychotherapy (IPT) wrote a commentary arguing that the group-delivered IPT treatment for eating disorders that we adapted and used in a recent trial (Stice, Rohde, et al., 2023) was less effective than the new dissonance-based eating disorder treatment (Body Project Treatment) because the group-delivered IPT did not contain all core elements, was not developmentally appropriate, was not tailored for people with eating disorders, and because our team lacked sufficient IPT expertise. In response, we note that the group-delivered IPT that we evaluated produced higher abstinence from binge eating and compensatory weight control behaviors (40%) than did individually delivered IPT in the only trial that also evaluated this treatment with a broad range of eating disorders (33%; Fairburn et al., 2015). The fact that the group-delivered IPT produced a higher abstinence rate than individually delivered IPT for a similar spectrum of patients appears to refute the stated concerns regarding the group-delivered version of IPT because it was not less effective than individually delivered IPT. We argue it is critical to establish that a treatment significantly outperforms alternative treatments with a distinct intervention target because only an active comparator controls for the potential confounds that can drive improvement in trials, including expectancies, demand characteristics, and nonspecific therapeutic effects. We also note that IPT for the treatment of eating disorders has not significantly outperformed three alternative treatments and that the evidence base for IPT may thus be driven by expectancies, demand characteristics, and nonspecific effects. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
期刊介绍:
The Journal of Consulting and Clinical Psychology® (JCCP) publishes original contributions on the following topics: the development, validity, and use of techniques of diagnosis and treatment of disordered behaviorstudies of a variety of populations that have clinical interest, including but not limited to medical patients, ethnic minorities, persons with serious mental illness, and community samplesstudies that have a cross-cultural or demographic focus and are of interest for treating behavior disordersstudies of personality and of its assessment and development where these have a clear bearing on problems of clinical dysfunction and treatmentstudies of gender, ethnicity, or sexual orientation that have a clear bearing on diagnosis, assessment, and treatmentstudies of psychosocial aspects of health behaviors. Studies that focus on populations that fall anywhere within the lifespan are considered. JCCP welcomes submissions on treatment and prevention in all areas of clinical and clinical–health psychology and especially on topics that appeal to a broad clinical–scientist and practitioner audience. JCCP encourages the submission of theory–based interventions, studies that investigate mechanisms of change, and studies of the effectiveness of treatments in real-world settings. JCCP recommends that authors of clinical trials pre-register their studies with an appropriate clinical trial registry (e.g., ClinicalTrials.gov, ClinicalTrialsRegister.eu) though both registered and unregistered trials will continue to be considered at this time.